Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? a nested case control study from the West of Scotland coronary prevention study

Gaw, A., Brown, E.A., Docherty, G. and Ford, I. (2000) Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? a nested case control study from the West of Scotland coronary prevention study. Atherosclerosis, 148(1), pp. 95-100. (doi:10.1016/S0021-9150(99)00259-2)

Full text not currently available from Enlighten.

Abstract

The clinical utility of a new assay for plasma lipoprotein(a)-cholesterol (Lp(a)-C) was assessed in parallel with our routine Lp(a) mass measurements in a nested-case control study of subjects within the placebo arm of the West of Scotland Coronary Prevention Study (WOSCOPS). A total of 238 control patients and 108 patients who had suffered a serious vascular event during the course of the WOSCOPS were examined. Lp(a) mass was assessed within 2 years of sampling by an ELISA method on baseline EDTA plasma samples which had been stored at −70°C. Subsequently, the Lp(a) mass was re-measured by an immunoturbidimetric assay ∼8 years after sampling. On the same stored aliquot the Lp(a)-C was measured. These analyses allowed us to assess whether the Lp(a)-C assay could provide any additional information over and above that which would be obtained from our Lp(a) mass assays. In addition the apo(a) isoform sizes of these subjects were measured using a high resolution immunoblotting system. The Lp(a)-C and Lp(a) mass measurements provided exactly the same information in the study, as they were equally non-discriminatory between cases and controls. The only difference between the two patient groups was the percentage of ‘null’ apo(a) alleles (control: 25.6% versus cases: 19.4%). We conclude that these results reinforce the concordance of the two assay systems and confirm that the Lp(a)-C assay provides no added information over and above that gained from traditional Lp(a) mass assays, which may be faster and less expensive.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ford, Professor Ian and Gaw, Dr Allan
Authors: Gaw, A., Brown, E.A., Docherty, G., and Ford, I.
Subjects:R Medicine > R Medicine (General)
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Robertson Centre
College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Atherosclerosis
Publisher:Elsevier Ireland Ltd
ISSN:0021-9150

University Staff: Request a correction | Enlighten Editors: Update this record